Inpatient Anticoagulation Management Services to Improve Transitions of Care
Andrea Resseguie PharmD, RPh, CACP Advanced Practice Clinical Specialist Anticoagulation Management Service
Inpatient Anticoagulation Management Services to Improve - - PowerPoint PPT Presentation
Inpatient Anticoagulation Management Services to Improve Transitions of Care Andrea Resseguie PharmD, RPh, CACP Advanced Practice Clinical Specialist Anticoagulation Management Service Learning Objectives List Inpatient Anticoagulation
Andrea Resseguie PharmD, RPh, CACP Advanced Practice Clinical Specialist Anticoagulation Management Service
– AMMO
Pharmacy AMS
– Monitor & order warfarin every day
– INR target range of 1.8 – 2.3 – Duration = 3 weeks
– INR target range dependent on VAD device – Duration = indefinite
Inpatient Anticoagulation Management Services cont.
Individual Responsibilities Orthopedic Surgery Resident/ Responding Clinician
surgery, and warfarin dose day of surgery
conditions
AMMO Primary Pharmacist
Messages”)
AMMO Secondary Pharmacist
EPIC
review consult & write AMMO intake note
DAWN AC
system
create daily inpatient roster
EPIC
RPh monitor & order warfarin
DAWN AC
RPh document daily progress note
– Referring physician (Surgeon) – Primary indication for anticoagulation (Orthopedic surgery) – Type of surgery – Date of surgery – INR target range – Duration
BWH Department of Pharmacy Anticoagulation Management Service (AMS) Patient Name: _______________________ Patient MRN: _______________________ DOB Age Gender: ____________________ Date: _______ Time: _______ Consult Reason: Asked to assist in warfarin management for the Anticoagulation Management for Inpatient Post-Operative Orthopedic (AMMO) service Indication for Anticoagulation: Orthopedic Surgery Type of Surgery: *** Target INR: *** - *** Duration of Therapy: *** Referring attending MD: _________________ Consult Received: The BWH Department of Pharmacy Anticoagulation Management Service will manage the warfarin dosing for Patient _______________ while an inpatient. For daily progress notes and dosing instructions please click on the AMS indicator in the patient header and an anticoagulation report will display on the right side of the screen. For any questions or concerns, please feel free to contact the AMS service via email (BWHRxInpatientAMS@partners.org) or contact the covering floor pharmacist for any urgent matters.
If patient is NOT in Dawn AC
If patient is ALREADY ACTIVE in Dawn AC
If patient is ALREADY in system but INACTIVE
Letters Tab: Select a custom message to send >>> Retrieve patient demographics from EMPI Once demographics have uploaded >>> Retrieve patient medications Write Note within Patient Profile: “AMMO following while inpatient for diagnosis (i.e. TKR) on date of surgery per physician (i.e. Dr. Wright). Your name
Routines
secondary RPh
Warfarin Initiation Dosing Protocol (INR Range 1.8 – 2.3)
POD INR Dose 1 <1.2 No change 1.2-1.3 No change or decrease by 1 mg 1.4-1.5 HOLD or decrease by 1-3 mg >1.5 HOLD 2 <1.3 Increase by 2 mg 1.3-1.5 Continue or increase by 1 mg
1.6-2.0 No change or decrease by 1-2 mg
>2.0 Decrease by 1 mg *Hold if INR increased by 0.6 in 24h 3 <1.3 Increase dose by 2 mg 1.3-1.5 No change or increase by 1 mg
1.6-2.0 No change or decrease by 1-2 mg
>2.0 Decrease by 1 mg or HOLD if INR increased 0.6 in 24h
– Comments Section = “PLEASE HOLD WARFARIN DOSE THIS EVE (MM/DD/YYYY). Call pharmacy with any questions on warfarin”
Inpatient AMMO patient discharged
– PT/INR tested day after discharge & Q Mon/Thurs – Reinforce education & counseling points
information in a timely fashion among themselves or to patient/ caregiver
and unclear instructions
likely buy into the importance of following the care plan
health care is coordinated across various settings and among different providers
be available to the patient upon discharge
– Inpatient >>> Outpatient
coordination, including patient/caregiver education, from admission through transition
points of transition
patient leaves a care setting
– TTR – Thrombosis – Bleeding
– INR Range of 2.0 – 3.0 – Duration of 3 months – Ensure follow up with outpatient provider to asses long term anticoagulation needs